Clinical trial
Nicotinamide Riboside in Ulcerative Colitis
NCT05561738 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Nicotinamide Riboside in Ulcerative Colitis
- Lead sponsor
- University of Pittsburgh
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- February 28, 2024
- Completion date
- June 30, 2026
- Enrollment
- 19 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ulcerative colitis